Institutional investors purchased a net $4.7 million shares of VSTM during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 54.83% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LIFESCI INDEX PARTNERS LLC Bought 41.6 Thousand shares of Verastem Inc